Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional Study to Assess Reaching of Cholesterol Target Values in Patients Treated With HMG-CoA Reductase Inhibitors in Bosnia and Herzegovina

NCT01483950 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01483950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01483950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional Study to Assess Reaching of Cholesterol Target Values in Patients Treated With HMG-CoA Reductase Inhibitors in Bosnia and Herzegovina
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
April 30, 2012
Completion date
January 31, 2013
Enrollment
800 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolaemia